DE1391524U - - Google Patents

Info

Publication number
DE1391524U
DE1391524U DENDAT1391524D DE1391524DU DE1391524U DE 1391524 U DE1391524 U DE 1391524U DE NDAT1391524 D DENDAT1391524 D DE NDAT1391524D DE 1391524D U DE1391524D U DE 1391524DU DE 1391524 U DE1391524 U DE 1391524U
Authority
DE
Germany
Prior art keywords
ßwax
youtileats
xejetung
xamt
wmmmt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1391524D
Other languages
German (de)
English (en)
Publication of DE1391524U publication Critical patent/DE1391524U/de
Active legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DENDAT1391524D Active DE1391524U (cg-RX-API-DMAC7.html)

Publications (1)

Publication Number Publication Date
DE1391524U true DE1391524U (cg-RX-API-DMAC7.html)

Family

ID=703164

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1391524D Active DE1391524U (cg-RX-API-DMAC7.html)

Country Status (1)

Country Link
DE (1) DE1391524U (cg-RX-API-DMAC7.html)

Similar Documents

Publication Publication Date Title
Pujol et al. In-vitro antifungal susceptibility of clinical and environmental Fusarium spp. strains.
DE1391524U (cg-RX-API-DMAC7.html)
Herbrecht et al. Efficacy of amphotericin B lipid complex in the treatment of invasive fungal infections in immunosuppressed paediatric patients
WO2005042386A1 (de) Vorrichtung zum vereinzeln von flachen sendungen in stehender position aus einem sendungsstapel
Della Vedova et al. Aspergillosis in domestic and wild birds from Argentina
US20190183729A1 (en) Premix formulation for parenteral use and packaging thereof
US10953078B2 (en) Treatment and/or prevention of sepsis
US20170128421A1 (en) Premix formulation for parenteral use and packaging thereof
DE69729425T2 (de) Nicht-virulentes Mycoplasma synoviae und Impfstoffe desselben
Venkatesh et al. Prophylaxis with lactoferrin, a novel antimicrobial agent, in a neonatal rat model of coinfection
Mikami et al. Synergistic postantifungal effect of flucytosine and fluconazole on Candida albicans
Smith et al. Experimental observations on the pathogenesis of necrobacillosis
CN116004759A (zh) 一种妥布霉素的微生物限度检测方法
Ostrosky-Zeichner et al. Effects of pentoxifylline or dexamethasone in combination with amphotericin B in experimental murine cerebral cryptococcosis: evidence of neuroexcitatory pathogenic mechanisms
EP3878542A1 (en) Filter membranes as antifoam level safeguards
Britt et al. Anthelmintic evaluation of a thiabendazole-resistant strain of Ostertagia circumcincta recovered from sheep in England
DE1502554U (cg-RX-API-DMAC7.html)
US20220257578A1 (en) Composition and method for treating candida auris infection
Abdele PRODUCTION OF BENEFICIAL LOCAL MICROORGANISM SOLUTION FROM HARAMAYA UNIVERSITY COMPOUND AND EFFECT OF ITS APPLICATION RATE AND ENSILING PERIOD ON QUALITY OF BARLEY (HORDEUM VULGARE) STRAW SILAGE
Marín et al. PHARMACOKINETICS OF TILDIPIROSIN AFTER INTRAVENOUS ADMINISTRATION TO HORSES AND EVALUATION OF ITS POTENTIAL CARDIOTOXIC EFFECT
Kauffman et al. Effect of Prophylactic Ketoconazole and Nystatin on Fungal Flora: Wirkung von prophylaktischen Ketoconazol‐und Nystatin‐Gaben auf die Pilzflora
EP4431083A1 (en) Formulation of dalbavancin
Sumano et al. Bioequivalence comparison of seventeen commercial oral enrofloxacins against the original pioneer preparation in broilers
Flückiger et al. Pneumonia in the immuncompromised host
KIRAL et al. Candida utilis: A Rare Cause of Septicemia in Two Immunocompetent Patients in the Pediatric Intensive Care Unit Candida utilis: Çocuk Yoğun Bakım Ünitesinde İzlenen İki İmmünokompetan Hastada Nadir Bir Sepsis Etkeni